UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005809
Receipt number R000006870
Scientific Title A single-blind and crossover study examining the efficacy of intranasal oxytocin administration for social impairments in subjects with pervasive developmental disorders
Date of disclosure of the study information 2011/06/21
Last modified on 2014/06/10 15:25:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A single-blind and crossover study examining the efficacy of intranasal oxytocin administration for social impairments in subjects with pervasive developmental disorders

Acronym

Pilot study examining the efficacy of intranasal oxytocin administration for social impairments in subjects with pervasive developmental disorders

Scientific Title

A single-blind and crossover study examining the efficacy of intranasal oxytocin administration for social impairments in subjects with pervasive developmental disorders

Scientific Title:Acronym

Pilot study examining the efficacy of intranasal oxytocin administration for social impairments in subjects with pervasive developmental disorders

Region

Japan


Condition

Condition

Pervasive developmental disorders

Classification by specialty

Psychiatry Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

1) Examining the efficacy of intranasal oxytocin administration for social impairments in subjects with pervasive developmental disorders
2) Examining the safety of intranasal oxytocin administration in subjects with pervasive developmental disorders
3) Examining changes in social impairments, as revealed by psychological tasks such as recognizing facial expressions and eye-tracking, induced by intranasal oxytocin administration in subjects with pervasive developmental disorders

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

psychological tasks related to social skills (face and facial expression recognition task, inference task utilizing social context), NIRS and eye tracking data

Key secondary outcomes

self rating scales, such as AQ(Autism Quatient), PARS(Pervasive Developmental Disorders Autism Society Japan Rating Scale), EPQ(Eysenck personality questionnaire), SPQ(Schizotypal Personality Questionnaire), TCI(Schizotypal Personality Questionnaire),SIQ(Social Intelligence Quantity)


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Single intranasal administration of 24 units oxytocin (Syntocinon spray)

Interventions/Control_2

Single intranasal administration of placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

55 years-old >

Gender

Male

Key inclusion criteria

1) Subjects diagnosed with high-functioning autism, Asperger disorder, or pervasive developmental disorder not otherwise specified using DSM-IV
2) Subjects with normal intelligent total IQ > 80 measured with Wechsler Adult Intelligent Scale

Key exclusion criteria

1) History of allergy for oxytocin
2) Cannot enter Magnetic Resonance Scanner
3) History of traumatic brain injury with any known cognitive consequences or loss of consciousness for more than 5 minutes
4) History of substance abuse or addiction
5) Instabilized with psychiatric comorbidity

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Haruhisa Ota

Organization

Showa University School of Medicine

Division name

Department of Neuropsychiatry

Zip code


Address

6-11-11 kitakarasuyama, setagaya-ku, Tokyo

TEL

03-3300-5231

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Karasuyama Hospital, Showa University School of Medicine

Division name

Department of Neuropsychiatry

Zip code


Address

mri.kenkyu@gmail.com

TEL


Homepage URL


Email



Sponsor or person

Institute

Department of Neuropsychiatry, Showa University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 06 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2010 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2011 Year 06 Month 01 Day

Last follow-up date

2012 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 06 Month 20 Day

Last modified on

2014 Year 06 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006870


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name